Reply to Pesko et al
- PMID: 35869851
- DOI: 10.1093/cid/ciac589
Reply to Pesko et al
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment on
-
Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients.Clin Infect Dis. 2022 Nov 30;75(11):2049-2050. doi: 10.1093/cid/ciac588. Clin Infect Dis. 2022. PMID: 35869852 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
